A Report on Non-Ionizing Radiation

GBM: Microwave News Article Archive (2004 - )

March 8, 2024

“‘Tumor Treating Fields’ Delivered via EM Induction Have Varied Effects Across Glioma Cell Lines and Electric Field Amplitudes,” American Journal of Cancer Research, February 28, 2024. “In summary, we have illustrated that the impact of Tumor Treating Fields can yield highly diverse effects on gene expression within distinct GBM stem cell lines.” Open access.

March 3, 2024

“Mobile Phone Use and Brain Tumour Risk – COSMOS, a Prospective Cohort Study,” Environment InternationalMarch 1, 2024. “Our findings suggest that the cumulative amount of mobile phone use is not associated with the risk of developing glioma, meningioma or acoustic neuroma.” Yet, there appears to be support for unexplained reports of increases in GBMs in the same COSMOS countries. More...

June 18, 2022

“Selective Cell Cycle Arrest in Glioblastoma Cell Lines by Quantum Molecular Resonance Alone or in Combination with Temozolomid,” British Journal of Cancer, June 17, 2022. A new “innovative option” to treat all-too-lethal glioblastoma with 4-64 MHz nanosecond pulses. “Quantum molecular resonance” therapy reduces cell proliferation in malignant cell lines with little effect on healthy cells. From Italy. Open Access.

June 11, 2021

A new analysis from the radiation group at the International Agency for Research on Cancer (IARC) calls into question the agency’s own classification of wireless radiation as a possible human carcinogen.

On May 27, IARC’s Isabelle Deltour presented the new analysis of the incidence of malignant brain tumors (glioma) in the Nordic countries —Denmark, Finland, Norway and Sweden— over the last several decades. She spoke at an online colloquium hosted by the German Federal Office of Radiation Protection, known as the BfS.

Deltour argued that the trends are mostly not “compatible” with those seen in the epidemiological studies —principally, Interphone and Lennart Hardell’s— that were the basis of IARC’s 2011 designation of RF radiation as a possible, or 2B, human carcinogen.

October 27, 2020

“An Overview of Potential Novel Mechanisms of Action Underlying Tumor Treating Fields-induced Cancer Cell Death and Their Clinical Implications,” International Journal of Radiation Biology, posted October 21, 2020.

“Recent findings implicate TTFields’ role in different important pathways such as DNA damage response and replication stress, ER stress, membrane permeability, autophagy, and immune response.”

May 19, 2020

“Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population,” Cureus, posted May 19, 2020.

“There was a significant increase in incidence from 0.73 to 4.49 per 100,000 over the 10-year period (p≤0.001).” Number of cases grew from 3 in 2008 to 21 in 2017. Open access.

February 17, 2020

Thyroid cancer among women is skyrocketing all over the world. Incidence is growing faster than for any other cancer. This has been going on for a long time, and the reasons why remain elusive.

The prevailing view is that there’s been an “epidemic of diagnosis” —that is, overdiagnosis— particularly following a screening program. The tumors have always been there, the argument goes, but new and better detection tools (ultrasound, for example) have made it easier to spot small ones, many of which would likely never present a real threat. In any case, thyroid cancer is not one of the bad ones; 98-99 percent of those diagnosed survive at least five years, the highest for all cancers. Watchful waiting is often the best prescription.

The only recognized cause for thyroid cancer is ionizing radiation.

December 13, 2019

The incidence of glioblastoma multiforme, GBM, the most aggressive type of brain tumor, though rising slowly over the last 20 years, has not jumped up in the U.S. and Canada, as it has in England and a number of other northern European countries, according to a new analysis of national brain tumor registry data.

Between 1995 and 2015, GBM rates went up 10% in the U.S. and 26% in Canada. In contrast, the increase in England over the same period was 110%.

June 11, 2019

GBM is going up in Denmark. The steady rise is very similar to what has been seen in England.

New government data, released in May by a member of the Danish Parliament, show a near doubling of this fatal brain tumor, glioblastoma multiforme, since the year 2000. You can see the trend by following the orange line in the histogram …

March 20, 2019

“Glioblastomas Have Doubled in Number in England Since Mobile Phones Were Introduced in 1995,” Pandora Foundation for Independent Research, March 19, 2019.

It's been a year since the Philips paper was published. This is the first discussion of its implications. See our report published last March.

February 20, 2019

It has been nearly eight years since an expert panel of the International Agency for Research on Cancer (IARC) classified RF radiation as a possible human carcinogen. Since then, neither the World Health Organization (WHO) nor the International Commission on Non-Ionizing Radiation Protection (ICNIRP) has recommended precautionary policies to limit potential health risks.

No U.S. health agency has yet advised the public to reduce RF exposures.

Even after two large animal studies —by the U.S. National Toxicology Program (NTP) and Italy’s Ramazzini Institute— presented clear evidence of a cancer link last year, the WHO has remained silent; ICNIRP responded by calling both animal studies unconvincing.

Now comes the Annual Review of Public Health, which on January 11 posted a paper by five leading epidemiologists who posit that, after a systematic review of all the human studies, they don’t see an elevated cancer risk. The takeaway is that the IARC classification was a mistake.

January 2, 2019

The incidence of brain tumors in Australia did not increase between 2003 and 2013, according to a new analysis by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and the Australian Centre for Electromagnetic Bioeffects Research (ACEBR). This means that there can be no link between the use of mobile phones and brain cancer, they claim. 

If such an association were true, “then the brain tumor rates would be higher than those that are observed,” states an ARPANSA press release that accompanies the new paper published in BMJ Open.

“People say mobile phones can cause cancer but our study showed this was not the case,” said ARPANSA’s Ken Karipidis, the lead author.

Others are skeptical. The work is incomplete and misleading —or worse, they say.

October 26, 2018

A U.K. epidemiologist has confirmed that glioblastoma (GBM), the most aggressive type of brain tumor, is on the rise in England. In a new paper, Frank de Vocht of the University of Bristol reports that he sees a significant and consistent increase in GBM in the frontal and temporal lobes of the brain over the last 20-30 years.

Alasdair Philips, an independent researcher based in Scotland, and three colleagues first documented the increase last March. It was not due to improved diagnosis, they said, but they could not pinpoint which “environmental or lifestyle factor” was responsible. There was one obvious possibility: cell phones.

October 18, 2018

“Analyses of Temporal and Spatial Patterns of GBM and other Brain Cancers Subtypes in Relation to Mobile Phones Using Synthetic Counterfactuals,” Environmental Research, posted October 17, 2018.

Frank de Vocht confirms that GBM is rising in the U.K. but argues that it’s “unlikely” that RF from cell phones is responsible.

March 25, 2018

The incidence of glioblastoma multiforme (GBM), the deadliest type of brain tumor, more than doubled in England between 1995 and 2015, according to a new analysis of national statistics. During that time, the number of cases of GBM rose from 983 to 2,531.

“We found a sustained and highly significant increase in GBM throughout the 21 years and across all ages,” said Alasdair Philips, the lead author of the study, which has just been released online by the peer-reviewed, open access, Journal of Environmental and Public Health.

“The incidence rate of GBM, the most aggressive and quickly fatal brain tumor, is rising dramatically in England while the rates for lower grade tumors have decreased, masking this dramatic trend in the overall data,” Philips told Microwave News from his home in Beeswing in southern Scotland, not far from the English border.

December 18, 2017

“Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients with Glioblastoma: A Randomized Clinical Trial,” JAMA, December 19, 2017.

Supplementing chemotherapy with 200 kHz E-fields increased progression-free survival (by 2.7 months to 6.7 months) and overall survival (by 4.9 months to 20.9 months) in patients with newly diagnosed glioblastoma. Both are statistically significant improvements.

August 30, 2017

The National Toxicology Program (NTP) will release the “complete results” of its $25 million project on cell phone cancer risks early next year, according to a statement posted on its Web site yesterday.

“The complete results from all the rats and mice studies will be available for peer review and public comment by early 2018,” the NTP states. The animals were exposed to GSM or CDMA radiation for two years before they were sacrificed and...

January 31, 2017

The incidence of glioblastoma multiforme (GBM), the most virulent and deadly type of brain cancer, is going up in the U.K., while the incidence there of other types of malignant brain tumors are declining, according to some newly published raw data.

Take a look at the two plots below and the trends are immediately apparent.

The incidence rates are not corrected for age, or any...

Pages

Subscribe to GBM: Microwave News Article Archive (2004 - )